1.
Reich K, Langley RG, Silvestre JF, Staumont-Salle D, Costanzo A, Pink A, Paller A, Katoh N, Wollenberg A, Warren RB, Øland CB, Tindberg A-M, Gjerum L, Simpson E. Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials . J of Skin [Internet]. 2024Mar.18 [cited 2024Jul.3];8(2):s375. Available from: https://jofskin.org/index.php/skin/article/view/2675